MultIceNtre Non-intERVentional Study for Efficacy,Safety Evaluation of BREZTRI in Pts With COPD in RussiA
NCT06422676 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2026-05-01
Summary
This is a retrospective-prospective, non-interventional, multi-centre study that will be conducted in routine clinical settings in Russia. Eligible patients with moderate to severe COPD routinely treated with BREZTRI will be observed according to routine clinical practice for up to 24 weeks.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-12-29
- Primary Completion
- 2024-12-18
- Completion
- 2024-12-18
Countries
- Russia
Study Locations
More Related Trials
-
EXACERBATIONS AND REAL-WORLD OUTOMES AMONG PATIENTS WITH COPD INITIATING BREZTRI (EROS+CP Japan Study)
NCT07103642 ·Status: COMPLETED
-
Budesonide / Formoterol in Treatment of Exacerbations of COPD
NCT00239278 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Patient With Frequent Exacerbations in Moscow
NCT07307781 ·Status: RECRUITING
-
The Effects of Inhaled Budesonide-formoterol-glycopyrronium in Moderate-to-severe COPD
NCT04675463 ·Status: UNKNOWN ·Phase: NA
-
Outcomes in Real-life After Initation of Treatment With Trixeo (Budesonide / Glycopyrronium / Formoterol)
NCT05862545 ·Status: COMPLETED
-
Effect of the Inhaled Triple Therapies Over the Small Airway in Biomass Exposure
NCT06571942 ·Status: RECRUITING ·Phase: PHASE4
-
Change in Patient-repOrted Outcomes in COPD Patients Newly Initiated on TRIXEO AEROSPHERE in Real worlD
NCT06368427 ·Status: COMPLETED
-
Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT01437540 ·Status: COMPLETED ·Phase: PHASE3
-
A Scintigraphy Study of PT010 in COPD Patients
NCT03906045 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Patient With Frequent COPD Exacerbations
NCT07221981 ·Status: ACTIVE_NOT_RECRUITING
-
Study Comparing Dual Combination of Product (Budesonide and Formoterol) Given Via Two Different Inhalers. To See Which One Results in the Best Effect on Breathing.
NCT04078126 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Symbicort Turbuhaler in Chinese Patients With COPD
NCT00421122 ·Status: COMPLETED ·Phase: PHASE3
-
Exacerbations and Their Outcomes International (EXACOS International)
NCT04928417 ·Status: COMPLETED
-
Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPD
NCT00476099 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Efficacy on Exercise Tolerance of Symbicort (Budesonide/Formoterol) Compared to Placebo and Oxis in Patients With Severe COPD
NCT00489853 ·Status: COMPLETED ·Phase: PHASE4
-
REported Outcomes in COPD With Trixeo in Real worlD
NCT05213611 ·Status: COMPLETED
-
Change in Symptom and Quality of Life in COPD by Budesonide/Glycopyrronium/Formoterol Fumarate Pressurized Metered Dose Inhaler (BGF pMDI)
NCT05219630 ·Status: COMPLETED
-
Pharmacokinetics, Safety and Tolerability of Twice-Daily Aclidinium Bromide/Formoterol Fumarate Fixed Dose Combination in Chinese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT03276078 ·Status: COMPLETED ·Phase: PHASE2
-
Safety & Efficacy of BCT197A2201 in COPD Patients Presenting With an Exacerbation
NCT01332097 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Formoterol/Fluticasone and Salmeterol/Fluticasone in Patients With Moderate-to-severe COPD
NCT01393145 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Study to Evaluate the Effects of BGF and GFF on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD
NCT03836677 ·Status: COMPLETED ·Phase: PHASE3
-
REported Outcomes in COPD With Trixeo in Real worlD in Germany
NCT05311306 ·Status: COMPLETED
-
Study to Evaluate the Safety and Efficacy of Formoterol in a Daily Dose of 18 µg (9 µg Twice Daily) in Japanese Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT01047553 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Efficacy and Safety of Formoterol in Patients With COPD Compared With Placebo in Patients in Japan, EU
NCT00628862 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
NCT03162055 ·Status: COMPLETED ·Phase: PHASE3